Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers

Go back to Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers
(NASDAQ: PGEN) Delayed: 7.69 -0.09 (1.16%)
Previous Close $7.78    52 Week High
Open $7.84    52 Week Low
Day High $7.91    P/E N/A 
Day Low $7.63    EPS
Volume 1,537,604